Aseptic meningitis possibly induced by adalimumab.
Jazeron
Aurélie
A
Lallier
Jean-Charles
JC
Rihn
Boris
B
Thiercelin
Marie-Catherine
MC
D000068879:Adalimumab; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008582:Meningitis, Aseptic / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D008875:Middle Aged
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab